4
Changes in Ownership
Lexeo Therapeutics, Inc. Filed Acc 0001209191-24-002928
Chief Medical Officer acquired 26,875 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Loading xslF345X05/doc4.xml…